article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

There was an article that examine the market for generic medicines in the Malaysia, following the introduction of the first generic patent in 2010 and the introduction of generic patent law in 2012. The market for medicines in Malaysia is divided between private clinics, private clinics, and pharmacies.

article thumbnail

2022 in review: Regulation starts to catch up with AI in pharma

Pharmaceutical Technology

At the recent Financial Times Global Pharma and Biotech 2022 Summit in London, Frank Nestle, Sanofi’s global head of research and chief scientific officer explained the company’s interest in AI as one where, “[AI] meets HI (human intelligence) and gives us predictive models. In a similar deal in November, Sanofi agreed to pay $21.5

Pharma 140
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Despite ban, Martin Shkreli can’t seem to kick the pharma habit

pharmaphorum

” That is certainly a departure from Shkreli’s earlier efforts to disrupt the healthcare category by inflating the price of critical HIV medication Daraprim by around 5,000% when he was chief executive at Turing Pharma. ” The post Despite ban, Martin Shkreli can’t seem to kick the pharma habit appeared first on.

Pharma 52
article thumbnail

The Dark Side of the Pharmaceutical Industry: Are Treatments Being Blocked for Profit?

Pharma Marketing Network

Conclusion The pharmaceutical industry is a critical part of the global healthcare system, but there are growing concerns that the industry is more concerned with profits than with improving public health. Pharmaceutical research and development: what do we get for all that money? W., & Lexchin, J. Fugh-Berman, A.

article thumbnail

Primate models in pharma: What the future holds

Pharmaceutical Technology

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. While multiple testing labs that use non-human primates for research were contacted for this article, all declined to comment amidst the most recent news coverage.

Pharma 98
article thumbnail

Dawn of a new indication: how to study drugs for aging 

Pharmaceutical Technology

Dr. Nir Barzilai, the scientific director for TAME and the director of the Institute for Aging Research at the Albert Einstein College of Medicine, New York, says projects like the TAME trial could be what regulators need to see to prove the validity of clinical trials in this area.

FDA 145
article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

Active immunotherapy through vaccination has a far lower cost than mAb-based therapies, representing an important decrease of economic burden for healthcare systems at a global scale. Dr Kosco-Vilbois holds a PhD in Anatomy and Immunology from the Medical College of Virginia/Virginia Commonwealth University School of Medicine, US.